Monkeypox Outbreak: Epidemiological, Clinical and Therapeutic Updates
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 6498
Special Issue Editor
Interests: infectious diseases; monkeypox; antiviral treatment; HIV; COVID-19; emerging infectious diseases; hepatitis viruses
Special Issue Information
Dear Colleagues,
The monkeypox (MPX) outbreak in 2022 was declared a global health emergency on 22 July 2022 by the World Health Organization, raising the alert for this infection to the highest level. According to the latest updates, over 25,000 cases of MPX have been confirmed since May 2022, mainly in young males. From the outset, MPX infection was characterized by polymorphic clinical manifestations and, in rare cases, a severe clinical course, leading to hospitalization and death. Although the number of new cases has drastically reduced in recent weeks, the alert remains high.
This Special Issue intends to update and highlight the epidemiology, clinical manifestations and therapeutic advances towards MPX infection. Particular focus will also be placed on possible prevention strategies, including risk education, vaccination campaigns and activities to prevent stigma.
Dr. Giuseppe Bruno
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- monkeypox
- epidemiology updates
- sexually-transmitted diseases
- tecovirimat
- cidofovir
- vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
